ARICEPT® (donepezil HCl tablets) is indicated for the treatment of mild, moderate, and severe dementia of the Alzheimer's type.

Important Safety Information

ARICEPT is well tolerated but may not be for everyone. People at risk for stomach ulcers or who take certain other medicines should tell their doctors because serious stomach problems, such as bleeding, may get worse.

Some people who take ARICEPT may experience fainting.

Some people may have nausea, vomiting, diarrhea, bruising, or not sleep well. Some people may have muscle cramps or loss of appetite or may feel tired. In studies these were usually mild and temporary.

For full prescribing information, please visit Prescribing Information.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

All quotes included in this Web site represent the individual experience of some doctors, some patients, and their caregivers. Individual responses to ARICEPT treatment may vary. Actual identities have been changed to protect individual privacy.

(i) The licensed material is being used for illustrative purposes only; and (ii) any person depicted in the licensed material, if any, is a model.

This site is intended for residents of the United States only. The products discussed herein may have different product labeling in different countries.

ARICEPT^® is a registered trademark of Eisai Co., Ltd.
© 2008-2010 Eisai Inc. and Pfizer Inc. All rights reserved. AAR00051N

Site Map  |  Prescribing Information  |  Legal Notices and Disclaimers  |  Privacy Policy